TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
Q2 2024 vs. Q1 2024
How the institutions holding TriSalus Life Sciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 25 | 27 | +2 |
| Shares | 926.0K | 1.79M | +859.1K (+92.8%) |
| Value | $9.03M | $9.20M | +$175.5K (+1.9%) |
New holders (6)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | 214,545 | $1.18M | 0.05% |
| Exos Asset Management LLC | 167,610 | $273.2K | 0.31% |
| Lido Advisors, LLC | 44,407 | $245.1K | 0.00% |
| Wolverine Asset Management LLC | 43,480 | $240.0K | 0.00% |
| HRT Financial LP | 35,541 | $196.0K | 0.00% |
| State Street Corp | 11,100 | $61.3K | 0.00% |
Sold out (4)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Wetherby Asset Management Inc | 34,950 | $340.8K |
| Tyche Wealth Partners LLC | 10,000 | $97.5K |
| Qube Research & Technologies Ltd | 5,490 | $53.5K |
| Macquarie Group Ltd | 291 | $3 |